-Analysts are expecting annual earnings growth of 33% in the Healthtech subsector, which is higher than its last year's earnings growth of 6.6% per year. (Simply Wall St.)
-Health technology 'healthtech' startups raised over $29 billion last year domestically (US) and over $57 billion globally (CB Insights). These record-breaking numbers were due in large part to COVID-19.
-Taylor Whitman, partner at Concord Health Partners thinks 2022's biggest trend will be another ancillary pandemic play, "With me areas, like remote patient monitoring, have seen explosive growth fueled by pandemic need"
Wearable Health Solutions, Inc. (OTCMKTS: WHSI) is set to launch its latest remote monitoring wearable device, the iHelp Max 4G.
Wearable Health Solutions Inc (OTCMKTS:WHSI) - is one of the more innovative companies in the medical devices space at this point in time and earlier this month on May 2 the company made a major new announcement.
The company announced at the time that it had made plans for the launch of its iHelp Max 4G product at some point in June 2022. It was a major new announcement and one that must have been taken note of by investors as well.
The iHelp Max 4G product in question is going to be marketed as a product that is far easier to use and reliable. In addition to that, the company is also going to highlight the fact it will also be easier to operate for the caregivers. On the other hand, the dealers who are going to provide support are also going to find the going easier.
At this point in time, it is going to be interesting to see if the Wearable Health Solutions stock can manage to come into focus among investors in the lead-up to June. Investors could do well to add it to their watch lists at this point.
India Globalization Capital Inc (NYSEAMERICAN:IGC) - The next stock to look into at this point could be the India Globalization Capital Inc stock. There has not been any news about the company in the past few days but back on April 18, the company made a major announcement.
It was announced that back on April 13 this year, an order had been entered at the United States District Court for the District of Maryland with regards to a final settlement. The settlement in question was between India Globalization Capital and two officers at the company against two shareholders' class action lawsuits.
VolitionRX Ltd (NYSEAMERICAN:VNRX) - In Q1, Cash and cash equivalents as of March 31, 2022, was $23.7 million compared with $20.6 million as of December 31, 2021. Net loss for the quarter came in at $7.7 million dollars compared to $6.1 million in the same quarter last year.
"I am delighted with the progress we are making, and in particular could not be prouder of the team's achievement in securing a global licensing and supply agreement for our Nu.Q® Vet Cancer Screening Test with Heska Corporation, one of the industry's leading companies," commented Cameron Reynolds, President and Chief Executive Officer of Volition.
Multiplan Corp (NYSE:MPLN) - Revenue reached $298 million during the period, representing a 16.9% increase over Q1 of the prior-year period.
Although net income reduced to 4.1% on the year to $44 million, adjusted EBITDA of $225.4 million for the quarter represents a 17.9% increase on the year prior, and the highest ever reached by the company in a single quarter. The company's 2022 full-year guidance remains unchanged.
"MultiPlan delivered very strong results, exceeding our expectations on revenue and Adjusted EBITDA for the first quarter of 2022. Our results continue to demonstrate the strength and recurring nature of our business model and the unique value MultiPlan provides to all stakeholders in a complex U.S. healthcare system," said Dale White, CEO of MultiPlan, in a statement.
InnnerScope Hearing Technologies Inc (OTCMKTS:INND) - Emerging direct to customer hearing technology company InnerScope Hearing Technologies Inc was in the news back on April 27 when it made a key announcement. The company announced at the time that it had decided to re-launch the e-commerce website for the iHear brand. That is also a brand of hearing products that are offered direct to customers.
Better Therapeutics Inc (NASDAQ:BTTX) will be in focus later this week as the company will report its first-quarter 2022 financial results before the market opens on Friday, May 13, 2022.
Management will host a conference call and webcast to provide a business update at 8:30 a.m. Eastern Time on Friday, May 13, 2022.
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States.
Start your research on WHSI here: https://topnewsguide.com/wearable-health-solutions-inc-whsi-profile/
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. TopNewsGuide 'TNG' is responsible for the production and distribution of this content. TNG is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. TNG authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. TNG is compensated three thousand dollars monthly via wire transfer by Wearable Health Solutions to produce and syndicate content related to WHSI. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.
CONTACT: To educate and attract more investors contact us at:
Mark McKelvie
editor@topnewsguide.com
(754) 233-0966
.
MULTIPLAN CORPORATION 
